Community Pharmacies and BioPharma: A New Era in Patient Care
The healthcare landscape is becoming increasingly complex, with a growing population of people with chronic conditions requiring specialized care.
Advanced therapies, including cell and gene therapies, are being approved at an accelerated rate, with 25% of FDA-approved therapies being approved in the last 18 months.
- Biologics, such as glucagon-like peptide-1 receptor agonists (GLP-1s), are gaining market share.
- Prescriptions for specialty medications have risen dramatically over the past 5 years.
Community pharmacies can help simplify and coordinate patient care as healthcare grows more complex.
Stay informed about the latest developments in BioPharma with a free newsletter from BioPharma Dive.
Author's summary: Community pharmacies and BioPharma collaborate to advance patient care.
More News
- The environmental impact of the 2026 World Cup
- iOS 26.1 Coming Soon: New Features for Your iPhone and Release Date
- MMJ BioPharma Cultivation: EXPOSÉ: DEA's Marijuana Licensing Scheme Exposed - MMJ BioPharma's Case Reveals DEA Contradiction Blocking FDA Approved Cannabis Medicine
- 'Google Guys’ back on top: Larry Page, Sergey Brin grow $50 billion richer, close in on Larry Ellison’s lead - Trending News | The Financial Express
- Why Experienced Lawyers Matter in a Personal Injury Case | NorthPennNow
- Giving States Waivers From Accountability Is a Dangerous Step Backward for Kids
- Pirates Listed as Potential Fit for Trent Grisham, Luis Arráez and Other Top Free Agents
- Biofuels and ethanol key to the future of U.S. agriculture - High Plains Journal
- Liam Hemsworth vs. Gabriella Brooks: Who Has the Higher Net Worth?
- Elon Musk could step down if Tesla pay plan is rejected